Asthma inhaler Dulera gets FDA approval - Related Stories - AAP SmartBrief
Links shared publicly online about this topic.
- 1,063total visits
Asthma inhaler Dulera gets FDA approval - Related Stories - AAP SmartBrief
Merck & Co. obtained FDA approval to sell Dulera, an inhaled asthma treatment for patients age 12 and older. Dulera, which comprises an inhaled corticosteroid and a long-acting beta agonist, is expected to compete with GlaxoSmithKline's Advair. <a href='/servlet/aaRedirect?url2=http%3a%2f%2fwww%2ebi
View full resource at smartbrief.com
Tags: Asthma, FDA, American Academy of Pediatrics, Advair, Merck & Co., Dulera
Most Recently Shared on June 27, 2010 at 4:09 pm By:
Asthma inhaler Dulera gets FDA approval http://sbne.ws/r/50EN
Advertisement
